Jeff Wallin

Jeff Wallin is an accomplished professional in the biotechnology and pharmaceutical sectors, with a robust background in research and biomarker development. Wallin served as a Senior Research Scientist at BAYER BIOTECH, Inc. and later as a Senior Research Scientist II at EXELIXIS, Inc. After progressing through roles at Genentech, including Group Leader and Sr. Research Scientist in Oncology Biomarker Development, Wallin held senior positions at Gilead Sciences, culminating in the role of Executive Director since November 2021. Wallin's experience also includes roles at Seattle Genetics as Sr. Director of Biomarkers and Diagnostics, and as a Postdoctoral Researcher at the University of California, where Wallin completed formative education with a focus on research.